Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2388]

Skin cancer suppressor found

Skin cancer suppressor found

FDA approves avapritinib for gastrointestinal stromal tumour with a rare mutation

FDA approves avapritinib for gastrointestinal stromal tumour with a rare mutation

Radical treatment of chronic oral infection before stem cell transplantation not necessary

Radical treatment of chronic oral infection before stem cell transplantation not necessary

Proton therapy lowers risk of side effects in cancer compared to traditional radiation

Proton therapy lowers risk of side effects in cancer compared to traditional radiation

Many younger patients with stomach cancer have a distinct disease

Many younger patients with stomach cancer have a distinct disease

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

Acute leukaemia patients treated with common therapy have increased risk for heart failure

Acute leukaemia patients treated with common therapy have increased risk for heart failure

SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence

SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence

Standard pathology tests outperform molecular subtyping in bladder cancer

Standard pathology tests outperform molecular subtyping in bladder cancer

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

More from ecancer